Brainsgate is a medical device company committed to developing a novel treatment modality, electrical SPG stimulation. This platform technology has been shown to increase blood flow to the brain and as a result has broad potential for treating central nervous system disorders. BrainsGate is currently focusing on:

1. Improve the outcome of patients suffering from ischemic stroke, in a 24 hour window after onset of symptoms.

2. Long-term SPG stimulation for the treatment of vascular dementia patients.

Focus: the spheno-palatine ganglion Two small nervous centers located above the roof of the mouth near the sinuses read more

Focus: ISS BrainsGate's product for the treatment of ischemic stroke and vascular dementia read more